Question-and-Answer Session
Unidentified Analyst
[Question Inaudible]
Bob Grieve
Gentlemen, for the web audience benefit, gentlemen, calculated calculus and said we make about $0.50 an animal for pets in the U.S.
Unidentified Analyst
[Question Inaudible]
Bob Grieve
Right, very sorry. In any case, yes, we would consider both on acquisitions if they are appropriate. We certainly aren't going to do them outside of the strategic context. We are going to really focus on this companion animal space and stay focused for the foreseeable future in that area. But if there are opportunities to grow critical mass and drive more revenue through and more penetration, we would love to do that.
Unidentified Analyst
[Question Inaudible]
Bob Grieve
I think in our universe, we'd be more reactive and proactive.
Unidentified Analyst
[Question Inaudible]
Bob Grieve
Yes. Just let me take this gentleman, Yes, sir.
Unidentified Analyst
[Question Inaudible]
Bob Grieve
Good.
Unidentified Analyst
[Question Inaudible]
Bob Grieve
Thank you. Now, the commentary again, for the web audience was, gentlemen, inquired of a veterinarian that practiced or lived in his own building, and she strongly endorsed the Heska brand and Heska products. And which in turn, I guess, charged you to consider to buy some stock. Is that the first summary? For the audience, I appreciate that a lot. Again, we've taken our position from a competitive standpoint and to focus on the highest possible quality in the product and the highest possible customer technical support that we can give. This is how we compete and this takes a bit more of ramp, a bit more of time. But we think it's an eminently more defensible position competitively.
Unidentified Analyst
[Question Inaudible]
Bob Grieve
The FDA, as I indicated the one slide on the pharmaceutical area. The FDA has jurisdiction on the disposable, single-use diagnostics and on vaccines. It's the United States Department of Agriculture. So there are two different bodies in the US. Yes, sir.
Unidentified Analyst
In your R&D program, what is the direction for your new product development?
Bob Grieve
Right, the question is on our R&D program, what's the direction for product development? Our primary focus is advanced diagnostics and specialty products solutions. And these specialty products were often, will seek specialty products that would compliment a diagnostic, for example. So that's generally the area and it gives me an opportunity also to emphasis one other thing.
We do a lot of internal R&D but as I showed, we do also product developments through partnerships. So, we're able to, in case of those In-Clinic analyzers that I showed in the first slide, we're able to go to people that manufacture devices or analyzers for human health. We're able to do a lot of modification and work with them to make them acceptable for veterinary use. And then, we serve as a channel partner.
- To read the full transcript on Seeking Alpha, click here »
